ACE-536
ACE-536-B-THAL-004
Phase 2 small_molecule active
Quick answer
ACE-536 for Beta-Thalassemia is a Phase 2 program (small_molecule) at Celgene Europe Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Celgene Europe Limited
- Indication
- Beta-Thalassemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active